Workshops focused around the roles and responsibilities of local cancer MDT members in the Lynch syndrome testing pathway.   Lynch syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers. Increases risk of developing bowel cancer to up to 80% Previously called hereditary non-polyposis colorectal cancer (HNPCC). LS affects approximately 1 in 300-1 in 400 people, with 200,000-300,000 people likely to have this condition in…